Journal Of Clinical And Experimental Hematopathology

The Journal of Clinical and Experimental Hematopathology is an international academic journal dedicated to the field of hematology, providing a professional platform for clinical doctors and experimental researchers to publish research results on blood and bone marrow diseases. This journal covers a wide range of topics from basic research to clinical applications, including cell morphology, immunohistochemistry, molecular biology, genetics, as well as clinical features and treatment methods of hematological diseases.

The purpose of the journal is to promote scientific progress in the field of hematology and improve understanding of the diagnosis and treatment of blood and bone marrow diseases. Its published content is not limited to original research articles, but also includes reviews, case reports, technological innovations, and clinical trial results. These publications are of great significance in guiding daily clinical practice and promoting the development of new therapies. The editorial committee of the journal is composed of renowned hematologists from around the world, who ensure that the content of the journal has high academic standards and an international perspective. The journal adopts a peer review process to ensure the rigor and reliability of the published research.

《临床与实验血液病理学杂志》是一本专注于血液病理学领域的国际学术期刊，它为临床医生和实验研究人员提供了一个专业的平台，用于发表有关血液和骨髓疾病的研究成果。该杂志覆盖了从基础研究到临床应用的广泛主题，包括细胞形态学、免疫组织化学、分子生物学、遗传学以及血液病的临床特征和治疗方法。

期刊的目的是促进血液病理学领域的科学进步，提高对血液和骨髓疾病诊断和治疗的理解。它发表的内容不仅限于原始研究文章，还包括综述、病例报告、技术创新和临床试验结果。这些出版物对于指导日常临床实践和推动新疗法的开发具有重要意义。杂志的编辑委员会由来自全球的知名血液病理学家组成，他们确保期刊的内容具有高学术标准和国际视野。期刊采用同行评审流程，以确保发表的研究具有严谨性和可靠性。

该刊已被国际权威数据库SCIE收录，该刊致力于发表经过严格同行评审的高质量原创文章，反映HEMATOLOGY领域的新进展、新技术、新成果，促进该领域科研交流和科研成果转化。该刊2023年影响因子为0.9，平均审稿速度为 11 Weeks ，近四年来没有被列入预警名单。如果您需要投稿发表服务及指导，可以联系我们的客服老师，我们专业专注服务期刊投稿协助10年，为您提供期刊投稿个性化定制服务，并且我们确保严格保密您的个人信息及稿件内容。